Extracellular matrix remodeling links vascular–stromal dysfunction to neuronal tau pathology in Progressive Supranuclear Palsy

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract Progressive supranuclear palsy-Richardson’s syndrome (PSP-RS) is a primary tauopathy lacking disease-modifying treatments, and the pathogenic mechanisms remain poorly understood. Here, combining patient-derived midbrain organoids with single-cell and bulk transcriptomics, quantitative proteomics, and functional assays, we identified extracellular matrix (ECM) dysregulation as an early pathogenic event. Vascular leptomeningeal-like cells (VLMCs) – a perivascular cell type recognized as a key component of the human dopaminergic lineage specification – emerged as dominant contributors, exhibiting excessive collagen deposition and upregulation of latent TGF-β-binding proteins. This fibrotic remodeling generated a stiff, adhesive microenvironment that mechanically retained and primed latent TGF-βs complexes for activation. Mechanical cues facilitated TGF-β release, triggering AKT-mTORC1 and RhoA/ROCK signaling pathways that converged on defective proteostasis, tau hyperphosphorylation and mislocalization, and synaptic degeneration. Pharmacological inhibition of ALK5/TGFBR1 restored cytoskeletal stability, autophagic flux, tau homeostasis, and neuronal morphology. Together, these findings identify ECM mechanotransduction, largely orchestrated by VLMC-derived components, as an upstream determinant of neuronal degeneration in PSP-RS and establish the ECM-TGF-β axis as a promising therapeutic target.
Full text 17,302 characters · extracted from preprint-html · click to expand
Extracellular matrix remodeling links vascular–stromal dysfunction to neuronal tau pathology in Progressive Supranuclear Palsy | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Extracellular matrix remodeling links vascular–stromal dysfunction to neuronal tau pathology in Progressive Supranuclear Palsy Elvira Parrotta, Clara Zannino, Desirèe Valente, Davide Bressan, and 14 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-7956425/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Progressive supranuclear palsy-Richardson’s syndrome (PSP-RS) is a primary tauopathy lacking disease-modifying treatments, and the pathogenic mechanisms remain poorly understood. Here, combining patient-derived midbrain organoids with single-cell and bulk transcriptomics, quantitative proteomics, and functional assays, we identified extracellular matrix (ECM) dysregulation as an early pathogenic event. Vascular leptomeningeal-like cells (VLMCs) – a perivascular cell type recognized as a key component of the human dopaminergic lineage specification – emerged as dominant contributors, exhibiting excessive collagen deposition and upregulation of latent TGF-β-binding proteins. This fibrotic remodeling generated a stiff, adhesive microenvironment that mechanically retained and primed latent TGF-βs complexes for activation. Mechanical cues facilitated TGF-β release, triggering AKT-mTORC1 and RhoA/ROCK signaling pathways that converged on defective proteostasis, tau hyperphosphorylation and mislocalization, and synaptic degeneration. Pharmacological inhibition of ALK5/TGFBR1 restored cytoskeletal stability, autophagic flux, tau homeostasis, and neuronal morphology. Together, these findings identify ECM mechanotransduction, largely orchestrated by VLMC-derived components, as an upstream determinant of neuronal degeneration in PSP-RS and establish the ECM-TGF-β axis as a promising therapeutic target. Biological sciences/Neuroscience/Molecular neuroscience Health sciences/Diseases/Neurological disorders/Neurodegeneration Biological sciences/Cell biology/Cytoskeleton/Actin Biological sciences/Cell biology/Cell signalling/Extracellular signalling molecules Progressive supranuclear palsy-Richardson syndrome (PSP-RS) tauopathy extracellular matrix (ECM) vascular leptomeningeal-like cells (VLMCs) TGF-β cytoskeleton synaptic vulnerability scRNA-seq transcriptomics proteomics Full Text Additional Declarations There is NO Competing Interest. Supplementary Files Supplementaryinformation.pdf Primers and antibodies Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-7956425","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":536551611,"identity":"ecc75ac1-4338-49b8-a102-4e057ae8585a","order_by":0,"name":"Elvira Parrotta","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAAvklEQVRIiWNgGAWjYDADfiA+AMQ8RKpPMGCQbIBqIVIPUIvBASiboBZz9rPPPnz88Ufe+EbuwQM//jDI2BPSYtmTbjxzRoKB4bYbeQkHe3iIcJjBgTRmZp4EA8ZtN3IMDjNIEKPl/DOwFvvNM0BaDIjRcgNiS+IGCZCWBCK0WM54xsw4I804ecaZNwYHew5I8PAcIKDFnD+NmeGDjZxtf3uO8Ycff2zs2RsIOQyNL0HIWZhaRsEoGAWjYBRgAgCgsjenWFwtjQAAAABJRU5ErkJggg==","orcid":"https://orcid.org/0000-0001-8145-3623","institution":"Department of Medical and Surgical Sciences, University of Catanzaro","correspondingAuthor":true,"prefix":"","firstName":"Elvira","middleName":"","lastName":"Parrotta","suffix":""},{"id":536551612,"identity":"1993e9ef-09dc-4874-8f4b-fa0d47e6a2ed","order_by":1,"name":"Clara Zannino","email":"","orcid":"","institution":"Department of Experimental Medical Science, Lund University, Lund, Sweden.","correspondingAuthor":false,"prefix":"","firstName":"Clara","middleName":"","lastName":"Zannino","suffix":""},{"id":536551613,"identity":"5225fcca-7dfb-423a-8cae-d040bcb61cf9","order_by":2,"name":"Desirèe Valente","email":"","orcid":"","institution":"University of Catanzaro Department of Experimental and Clinical Medicine","correspondingAuthor":false,"prefix":"","firstName":"Desirèe","middleName":"","lastName":"Valente","suffix":""},{"id":536551614,"identity":"28981bc9-df8d-4607-98de-f36e7f29a561","order_by":3,"name":"Davide Bressan","email":"","orcid":"https://orcid.org/0000-0003-4757-2535","institution":"University of Trento, Department of Cellular, Computational and Integrative Biology, Trento, Italy.","correspondingAuthor":false,"prefix":"","firstName":"Davide","middleName":"","lastName":"Bressan","suffix":""},{"id":536551615,"identity":"eb12ca57-3d1c-437f-b82c-1826da52c4e1","order_by":4,"name":"Andreas Bruzelius","email":"","orcid":"","institution":"Lund University","correspondingAuthor":false,"prefix":"","firstName":"Andreas","middleName":"","lastName":"Bruzelius","suffix":""},{"id":536551616,"identity":"78db57cb-f957-4797-a930-40b4adb89b97","order_by":5,"name":"Caterina Gabriele","email":"","orcid":"https://orcid.org/0000-0003-2584-1335","institution":"University Magna Greacia of Catanzaro, Departments of Experimental and Clinical Medicine","correspondingAuthor":false,"prefix":"","firstName":"Caterina","middleName":"","lastName":"Gabriele","suffix":""},{"id":536551617,"identity":"dd525711-75ee-4fe0-b556-41c72c22e78c","order_by":6,"name":"Stefania Scalise","email":"","orcid":"https://orcid.org/0000-0001-6979-1486","institution":"University of Catanzaro Department of Experimental and Clinical Medicine","correspondingAuthor":false,"prefix":"","firstName":"Stefania","middleName":"","lastName":"Scalise","suffix":""},{"id":536551618,"identity":"2c769ac8-ad8e-4f0f-be68-23abb7334031","order_by":7,"name":"Raffaele Covello","email":"","orcid":"","institution":"Department of Experimental and Clinical Medicine, University of Magna Grecia, 88100, Catanzaro, Italy.","correspondingAuthor":false,"prefix":"","firstName":"Raffaele","middleName":"","lastName":"Covello","suffix":""},{"id":536551619,"identity":"3d5d38be-0ae7-4a28-b39f-cc9036322f42","order_by":8,"name":"Giorgia Benedetto","email":"","orcid":"","institution":"University of Catanzaro Department of Medical and Surgical Sciences","correspondingAuthor":false,"prefix":"","firstName":"Giorgia","middleName":"","lastName":"Benedetto","suffix":""},{"id":536551620,"identity":"d1c6228a-2c93-48cf-8459-9453298874c2","order_by":9,"name":"Mariagrazia Talarico","email":"","orcid":"","institution":"Department of Experimental and Clinical Medicine, University of Magna Grecia, 88100, Catanzaro, Italy.","correspondingAuthor":false,"prefix":"","firstName":"Mariagrazia","middleName":"","lastName":"Talarico","suffix":""},{"id":536551621,"identity":"ec59551e-b413-4921-a680-a015aa91217c","order_by":10,"name":"Vittorio Abbonante","email":"","orcid":"","institution":"Department of Health Sciences, University Magna Graecia of Catanzaro, 88100, Catanzaro, Italy.","correspondingAuthor":false,"prefix":"","firstName":"Vittorio","middleName":"","lastName":"Abbonante","suffix":""},{"id":536551622,"identity":"f0af8565-6b63-4383-b4f6-e562cb0178b5","order_by":11,"name":"Andrea Quattrone","email":"","orcid":"","institution":"Institute of Neurology, Department of Medical and Surgical Sciences, ‘Magna Graecia’ University","correspondingAuthor":false,"prefix":"","firstName":"Andrea","middleName":"","lastName":"Quattrone","suffix":""},{"id":536551623,"identity":"a5efed01-bb27-4aa8-8c0c-0737dd4fc4e6","order_by":12,"name":"Marco Gaspari","email":"","orcid":"https://orcid.org/0000-0002-5411-8800","institution":"Magna Graecia University","correspondingAuthor":false,"prefix":"","firstName":"Marco","middleName":"","lastName":"Gaspari","suffix":""},{"id":536551624,"identity":"28165b49-37ee-4d3c-9014-0ead60eef2a2","order_by":13,"name":"Aldo Quattrone","email":"","orcid":"","institution":"Policlinico Magna Graecia","correspondingAuthor":false,"prefix":"","firstName":"Aldo","middleName":"","lastName":"Quattrone","suffix":""},{"id":536551625,"identity":"420fd3c7-42d4-4391-9004-9e86a61ae20c","order_by":14,"name":"Fulvio Chiacchiera","email":"","orcid":"","institution":"University of Trento, Department of Cellular, Computational and Integrative Biology, Trento, Italy.","correspondingAuthor":false,"prefix":"","firstName":"Fulvio","middleName":"","lastName":"Chiacchiera","suffix":""},{"id":536551626,"identity":"8abd794d-2490-48e5-bed5-a382123659b4","order_by":15,"name":"Graziano Martello","email":"","orcid":"","institution":"Department of Biology, University of Padua, Padua, Italy","correspondingAuthor":false,"prefix":"","firstName":"Graziano","middleName":"","lastName":"Martello","suffix":""},{"id":536551627,"identity":"5b99b49b-2277-4dff-b904-274a66a8e4f4","order_by":16,"name":"Alessandro Fiorenzano","email":"","orcid":"","institution":"Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131, Naples, Italy","correspondingAuthor":false,"prefix":"","firstName":"Alessandro","middleName":"","lastName":"Fiorenzano","suffix":""},{"id":536551628,"identity":"37476358-a7da-4ccc-bede-5c109ddb32a6","order_by":17,"name":"Giovanni Cuda","email":"","orcid":"https://orcid.org/0000-0001-6313-1866","institution":"University Magna Graecia","correspondingAuthor":false,"prefix":"","firstName":"Giovanni","middleName":"","lastName":"Cuda","suffix":""}],"badges":[],"createdAt":"2025-10-27 11:48:35","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-7956425/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-7956425/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":95802231,"identity":"58cece96-f06e-49c5-9a7f-f4ff4ad0e38c","added_by":"auto","created_at":"2025-11-13 08:27:13","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3315149,"visible":true,"origin":"","legend":"Article File","description":"","filename":"Zanninoetal.DraftFigs.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7956425/v1_covered_ccc03c61-2a5f-49f0-bfd9-029f343cb15b.pdf"},{"id":95495804,"identity":"ecda318f-d53a-4497-836e-9003af11d158","added_by":"auto","created_at":"2025-11-10 04:06:41","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":151514,"visible":true,"origin":"","legend":"Primers and antibodies","description":"","filename":"Supplementaryinformation.pdf","url":"https://assets-eu.researchsquare.com/files/rs-7956425/v1/6a25088acea01b091869bf3f.pdf"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Extracellular matrix remodeling links vascular–stromal dysfunction to neuronal tau pathology in Progressive Supranuclear Palsy","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Progressive supranuclear palsy-Richardson syndrome (PSP-RS), tauopathy, extracellular matrix (ECM), vascular leptomeningeal-like cells (VLMCs), TGF-β, cytoskeleton, synaptic vulnerability, scRNA-seq, transcriptomics, proteomics","lastPublishedDoi":"10.21203/rs.3.rs-7956425/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-7956425/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"Progressive supranuclear palsy-Richardson’s syndrome (PSP-RS) is a primary tauopathy lacking disease-modifying treatments, and the pathogenic mechanisms remain poorly understood. Here, combining patient-derived midbrain organoids with single-cell and bulk transcriptomics, quantitative proteomics, and functional assays, we identified extracellular matrix (ECM) dysregulation as an early pathogenic event. Vascular leptomeningeal-like cells (VLMCs) – a perivascular cell type recognized as a key component of the human dopaminergic lineage specification – emerged as dominant contributors, exhibiting excessive collagen deposition and upregulation of latent TGF-β-binding proteins. This fibrotic remodeling generated a stiff, adhesive microenvironment that mechanically retained and primed latent TGF-βs complexes for activation. Mechanical cues facilitated TGF-β release, triggering AKT-mTORC1 and RhoA/ROCK signaling pathways that converged on defective proteostasis, tau hyperphosphorylation and mislocalization, and synaptic degeneration. Pharmacological inhibition of ALK5/TGFBR1 restored cytoskeletal stability, autophagic flux, tau homeostasis, and neuronal morphology. Together, these findings identify ECM mechanotransduction, largely orchestrated by VLMC-derived components, as an upstream determinant of neuronal degeneration in PSP-RS and establish the ECM-TGF-β axis as a promising therapeutic target.","manuscriptTitle":"Extracellular matrix remodeling links vascular–stromal dysfunction to neuronal tau pathology in Progressive Supranuclear Palsy","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-11-10 04:06:36","doi":"10.21203/rs.3.rs-7956425/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"a0f98035-80be-4176-9918-1c10b1d40aaa","owner":[],"postedDate":"November 10th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":57051058,"name":"Biological sciences/Neuroscience/Molecular neuroscience"},{"id":57051059,"name":"Health sciences/Diseases/Neurological disorders/Neurodegeneration"},{"id":57051060,"name":"Biological sciences/Cell biology/Cytoskeleton/Actin"},{"id":57051061,"name":"Biological sciences/Cell biology/Cell signalling/Extracellular signalling molecules"}],"tags":[],"updatedAt":"2025-11-12T17:11:28+00:00","versionOfRecord":[],"versionCreatedAt":"2025-11-10 04:06:36","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-7956425","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-7956425","identity":"rs-7956425","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00